D-22213

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameD-22213
Drug Alias NameD-22213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBombesin receptor antagonists
TargetsBombesin receptor
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmerican Society Of Travel Advisors (Asta)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsta Medica Ag
Active IndicationsN/A
Inactive IndicationsLymphoma

Other Information

ATC CodeN/A
Related LinksN/A